Global and United States Eye Disorders Treatments Market Report & Forecast 2023-2028

Report ID: 1825560 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Eye Disorders Treatments Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Eye Disorders Treatments Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Eye Disorders Treatments Market Size for the Year 2017-2028
        1.2.2 Global Eye Disorders Treatments Market Size for the Year 2017-2028
    1.3 Eye Disorders Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Eye Disorders Treatments in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Eye Disorders Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Eye Disorders Treatments Market Dynamics
        1.4.1 Eye Disorders Treatments Industry Trends
        1.4.2 Eye Disorders Treatments Market Drivers
        1.4.3 Eye Disorders Treatments Market Challenges
        1.4.4 Eye Disorders Treatments Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Eye Disorders Treatments by Type
    2.1 Eye Disorders Treatments Market Segment by Type
        2.1.1 Cataract Surgery Devices
        2.1.2 Glaucoma Surgery Devices
        2.1.3 Vitreoretinal Surgery Devices
        2.1.4 Refractive Surgery Devices
    2.2 Global Eye Disorders Treatments Market Size by Type (2017, 2022 & 2028)
    2.3 Global Eye Disorders Treatments Market Size by Type (2017-2028)
    2.4 United States Eye Disorders Treatments Market Size by Type (2017, 2022 & 2028)
    2.5 United States Eye Disorders Treatments Market Size by Type (2017-2028)
3 Eye Disorders Treatments by Application
    3.1 Eye Disorders Treatments Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Eye Disorders Treatments Market Size by Application (2017, 2022 & 2028)
    3.3 Global Eye Disorders Treatments Market Size by Application (2017-2028)
    3.4 United States Eye Disorders Treatments Market Size by Application (2017, 2022 & 2028)
    3.5 United States Eye Disorders Treatments Market Size by Application (2017-2028)
4 Global Eye Disorders Treatments Competitor Landscape by Company
    4.1 Global Eye Disorders Treatments Market Size by Company
        4.1.1 Top Global Eye Disorders Treatments Companies Ranked by Revenue (2021)
        4.1.2 Global Eye Disorders Treatments Revenue by Player (2017-2022)
    4.2 Global Eye Disorders Treatments Concentration Ratio (CR)
        4.2.1 Eye Disorders Treatments Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Eye Disorders Treatments in 2021
        4.2.3 Global Eye Disorders Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Eye Disorders Treatments Headquarters, Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Eye Disorders Treatments Headquarters and Area Served
        4.3.2 Global Eye Disorders Treatments Companies Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Eye Disorders Treatments Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Eye Disorders Treatments Market Size by Company
        4.5.1 Top Eye Disorders Treatments Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Eye Disorders Treatments Revenue by Players (2020, 2021 & 2022)
5 Global Eye Disorders Treatments Market Size by Region
    5.1 Global Eye Disorders Treatments Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Eye Disorders Treatments Market Size by Region (2017-2028)
        5.2.1 Global Eye Disorders Treatments Market Size by Region: 2017-2022
        5.2.2 Global Eye Disorders Treatments Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Eye Disorders Treatments Market Size YoY Growth 2017-2028
        6.1.2 North America Eye Disorders Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Eye Disorders Treatments Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Eye Disorders Treatments Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Eye Disorders Treatments Market Size YoY Growth 2017-2028
        6.3.2 Europe Eye Disorders Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Eye Disorders Treatments Market Size YoY Growth 2017-2028
        6.4.2 Latin America Eye Disorders Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Eye Disorders Treatments Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Eye Disorders Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Company Details
        7.1.2 Johnson & Johnson Business Overview
        7.1.3 Johnson & Johnson Eye Disorders Treatments Introduction
        7.1.4 Johnson & Johnson Revenue in Eye Disorders Treatments Business (2017-2022)
        7.1.5 Johnson & Johnson Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Eye Disorders Treatments Introduction
        7.2.4 Novartis Revenue in Eye Disorders Treatments Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Alimera Sciences
        7.3.1 Alimera Sciences Company Details
        7.3.2 Alimera Sciences Business Overview
        7.3.3 Alimera Sciences Eye Disorders Treatments Introduction
        7.3.4 Alimera Sciences Revenue in Eye Disorders Treatments Business (2017-2022)
        7.3.5 Alimera Sciences Recent Development
    7.4 Teva Pharmaceutical
        7.4.1 Teva Pharmaceutical Company Details
        7.4.2 Teva Pharmaceutical Business Overview
        7.4.3 Teva Pharmaceutical Eye Disorders Treatments Introduction
        7.4.4 Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2017-2022)
        7.4.5 Teva Pharmaceutical Recent Development
    7.5 Eyetech Pharmaceuticals
        7.5.1 Eyetech Pharmaceuticals Company Details
        7.5.2 Eyetech Pharmaceuticals Business Overview
        7.5.3 Eyetech Pharmaceuticals Eye Disorders Treatments Introduction
        7.5.4 Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2017-2022)
        7.5.5 Eyetech Pharmaceuticals Recent Development
    7.6 Refocus Group
        7.6.1 Refocus Group Company Details
        7.6.2 Refocus Group Business Overview
        7.6.3 Refocus Group Eye Disorders Treatments Introduction
        7.6.4 Refocus Group Revenue in Eye Disorders Treatments Business (2017-2022)
        7.6.5 Refocus Group Recent Development
    7.7 VisionCare Ophthalmic Technologies
        7.7.1 VisionCare Ophthalmic Technologies Company Details
        7.7.2 VisionCare Ophthalmic Technologies Business Overview
        7.7.3 VisionCare Ophthalmic Technologies Eye Disorders Treatments Introduction
        7.7.4 VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2017-2022)
        7.7.5 VisionCare Ophthalmic Technologies Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Eye Disorders Treatments Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Eye Disorders Treatments Market Trends
    Table 3. Eye Disorders Treatments Market Drivers
    Table 4. Eye Disorders Treatments Market Challenges
    Table 5. Eye Disorders Treatments Market Restraints
    Table 6. Global Eye Disorders Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Eye Disorders Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Eye Disorders Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Eye Disorders Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Eye Disorders Treatments Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Eye Disorders Treatments Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Eye Disorders Treatments Revenue Share by Player, 2017-2022
    Table 13. Global Eye Disorders Treatments Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Eye Disorders Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Disorders Treatments as of 2021)
    Table 15. Top Players of Eye Disorders Treatments in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Eye Disorders Treatments Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Eye Disorders Treatments Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Eye Disorders Treatments Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Eye Disorders Treatments Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Eye Disorders Treatments Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Eye Disorders Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Eye Disorders Treatments Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Eye Disorders Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Eye Disorders Treatments Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Eye Disorders Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Eye Disorders Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Eye Disorders Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Johnson & Johnson Company Details
    Table 31. Johnson & Johnson Business Overview
    Table 32. Johnson & Johnson Eye Disorders Treatments Product
    Table 33. Johnson & Johnson Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 34. Johnson & Johnson Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Eye Disorders Treatments Product
    Table 38. Novartis Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Alimera Sciences Company Details
    Table 41. Alimera Sciences Business Overview
    Table 42. Alimera Sciences Eye Disorders Treatments Product
    Table 43. Alimera Sciences Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 44. Alimera Sciences Recent Development
    Table 45. Teva Pharmaceutical Company Details
    Table 46. Teva Pharmaceutical Business Overview
    Table 47. Teva Pharmaceutical Eye Disorders Treatments Product
    Table 48. Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 49. Teva Pharmaceutical Recent Development
    Table 50. Eyetech Pharmaceuticals Company Details
    Table 51. Eyetech Pharmaceuticals Business Overview
    Table 52. Eyetech Pharmaceuticals Eye Disorders Treatments Product
    Table 53. Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 54. Eyetech Pharmaceuticals Recent Development
    Table 55. Refocus Group Company Details
    Table 56. Refocus Group Business Overview
    Table 57. Refocus Group Eye Disorders Treatments Product
    Table 58. Refocus Group Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 59. Refocus Group Recent Development
    Table 60. VisionCare Ophthalmic Technologies Company Details
    Table 61. VisionCare Ophthalmic Technologies Business Overview
    Table 62. VisionCare Ophthalmic Technologies Eye Disorders Treatments Product
    Table 63. VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2017-2022) & (US$ Million)
    Table 64. VisionCare Ophthalmic Technologies Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Eye Disorders Treatments Product Picture
    Figure 2. Global Eye Disorders Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Eye Disorders Treatments Market Size 2017-2028 (US$ Million)
    Figure 4. United States Eye Disorders Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Eye Disorders Treatments Market Size 2017-2028 (US$ Million)
    Figure 6. United States Eye Disorders Treatments Market Share in Global 2017-2028
    Figure 7. Eye Disorders Treatments Report Years Considered
    Figure 8. Product Picture of Cataract Surgery Devices
    Figure 9. Product Picture of Glaucoma Surgery Devices
    Figure 10. Product Picture of Vitreoretinal Surgery Devices
    Figure 11. Product Picture of Refractive Surgery Devices
    Figure 12. Global Eye Disorders Treatments Market Share by Type in 2022 & 2028
    Figure 13. Global Eye Disorders Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Eye Disorders Treatments Market Share by Type (2017-2028)
    Figure 15. United States Eye Disorders Treatments Market Share by Type in 2022 & 2028
    Figure 16. United States Eye Disorders Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Eye Disorders Treatments Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Others
    Figure 21. Global Eye Disorders Treatments Market Share by Application in 2022 & 2028
    Figure 22. Global Eye Disorders Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Eye Disorders Treatments Market Share by Application (2017-2028)
    Figure 24. United States Eye Disorders Treatments Market Share by Application in 2022 & 2028
    Figure 25. United States Eye Disorders Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Eye Disorders Treatments Market Share by Application (2017-2028)
    Figure 27. North America Eye Disorders Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Eye Disorders Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Eye Disorders Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Eye Disorders Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Eye Disorders Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Eye Disorders Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Johnson & Johnson Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 57. Alimera Sciences Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 58. Teva Pharmaceutical Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 59. Eyetech Pharmaceuticals Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 60. Refocus Group Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 61. VisionCare Ophthalmic Technologies Revenue Growth Rate in Eye Disorders Treatments Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson
Novartis
Alimera Sciences
Teva Pharmaceutical
Eyetech Pharmaceuticals
Refocus Group
VisionCare Ophthalmic Technologies
Frequently Asked Questions
Eye Disorders Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Eye Disorders Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Eye Disorders Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports